Variant report

Variant	esv1797009
Chromosome Location	chr10:54011665-54018292
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:54008362..54009880-chr10:54016820..54018368,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MBL2-5	chr10:54013131-54013200	ENSG00000236671
2	lnc-MBL2-5	chr10:54011725-54012596	ENSG00000236671.3
3	lnc-MBL2-5	chr10:54013131-54013200	ENSG00000236671.3
4	lnc-MBL2-5	chr10:54011725-54012596	ENSG00000236671

Variant related genes	Relation type
ZNF280B	miRNA target sites

Extended variants
information (count: 222 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:222 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10824300	chr10:54011665-54011666	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs555847825	chr10:54011741-54011742	Weak transcription Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
3	rs117696529	chr10:54011752-54011753	Weak transcription Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
4	rs192727304	chr10:54011773-54011774	Weak transcription Active TSS Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
5	rs11594952	chr10:54011813-54011814	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
6	rs554044392	chr10:54011839-54011840	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
7	rs183123145	chr10:54011840-54011841	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
8	rs546126608	chr10:54011856-54011857	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
9	rs552347845	chr10:54011887-54011888	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
10	rs139465706	chr10:54011906-54011907	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs576002638	chr10:54011921-54011922	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs565770066	chr10:54011929-54011930	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs541432025	chr10:54011936-54011937	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs369092970	chr10:54011960-54011961	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs561325424	chr10:54012021-54012022	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs528033111	chr10:54012062-54012063	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs548183678	chr10:54012080-54012081	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs567836796	chr10:54012081-54012082	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs186869067	chr10:54012126-54012127	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
20	rs191337623	chr10:54012161-54012162	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs185046791	chr10:54012163-54012164	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs189425459	chr10:54012164-54012165	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs200766775	chr10:54012169-54012170	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs570222139	chr10:54012192-54012193	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs73346989	chr10:54012256-54012257	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs192362274	chr10:54012267-54012268	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs566064659	chr10:54012273-54012274	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs115366986	chr10:54012301-54012302	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs536577173	chr10:54012314-54012315	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs77510299	chr10:54012321-54012322	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs149686067	chr10:54012322-54012323	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs12247458	chr10:54012337-54012338	Weak transcription Enhancers Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs556441804	chr10:54012390-54012391	Weak transcription Enhancers Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
34	rs372859212	chr10:54012405-54012406	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
35	rs7086430	chr10:54012431-54012432	Weak transcription Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs538745975	chr10:54012435-54012436	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
37	rs185212819	chr10:54012438-54012439	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
38	rs561384054	chr10:54012513-54012514	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
39	rs571702126	chr10:54012539-54012540	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
40	rs540728003	chr10:54012555-54012556	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
41	rs563796808	chr10:54012562-54012563	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
42	rs533591180	chr10:54012578-54012579	Weak transcription Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
43	rs79439004	chr10:54012603-54012604	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs543628667	chr10:54012613-54012614	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs114963291	chr10:54012615-54012616	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs529596403	chr10:54012671-54012672	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs549688914	chr10:54012712-54012713	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs566126227	chr10:54012759-54012760	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs10824303	chr10:54012783-54012784	Weak transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs145522553	chr10:54012803-54012804	Weak transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Esophageal cancer	21851588	CNVD
Prostate cancer	18632612	CNVD
Autism	18414403	CNVD
Cockayne syndrome	18421352	CNVD
Glioblastoma	16823260	CNVD
Medulloblastoma	16968546	CNVD
Neuroblastoma	17533364	CNVD
T-cell lymphomas	19863542	CNVD
Testicular germ cell tumor	18059402	CNVD
Squamous cell cancer	21044232	CNVD
Glioma	21971842	CNVD
Cancer	21637783	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Obesity	21956041	CNVD
Developmental delay	21948486	CNVD
Dysmorphic features	21948486	CNVD
Epilepsy	21948486	CNVD
Intellectual disability	21948486	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Metanephric adenoma	20802469	CNVD
Autism	20841430	CNVD
Mental retardation	17124404	CNVD
Epilepsy	20923578	CNVD
Prostate cancer	16573809	CNVD
Schizophrenia	19329560	CNVD
Heart failure	18772530	CNVD
Heart failure	18854381	CNVD
Hyperglycemia	19060297	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Glioblastoma multiforme	22286061	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Usher syndrome	20538994	CNVD
Glioblastoma multiforme	17002787	CNVD

Chromatin state (count:74 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:54002000-54042000	Weak transcription	Aorta	Aorta
2	chr10:54008800-54016600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
3	chr10:54010000-54023200	Weak transcription	Psoas Muscle	Psoas
4	chr10:54010800-54014200	Active TSS	Fetal Muscle Leg	muscle
5	chr10:54011000-54016600	Weak transcription	HSMM	muscle
6	chr10:54011200-54013200	Active TSS	HSMMtube	muscle
7	chr10:54011400-54011800	Weak transcription	Fetal Heart	heart
8	chr10:54011400-54014600	Weak transcription	Skeletal Muscle Male	skeletal muscle
9	chr10:54011600-54012400	Weak transcription	Fetal Muscle Trunk	muscle
10	chr10:54011600-54012400	Enhancers	Skeletal Muscle Female	skeletal muscle
11	chr10:54011800-54012400	Enhancers	Fetal Heart	heart
12	chr10:54012200-54012800	Active TSS	Right Atrium	heart
13	chr10:54012400-54013800	Active TSS	Fetal Muscle Trunk	muscle
14	chr10:54012400-54014600	Weak transcription	Skeletal Muscle Female	skeletal muscle
15	chr10:54012800-54019000	Weak transcription	Right Atrium	heart
16	chr10:54013200-54014600	Weak transcription	HSMMtube	muscle
17	chr10:54014200-54016800	Weak transcription	Fetal Muscle Leg	muscle
18	chr10:54014600-54014800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr10:54014600-54014800	Enhancers	HSMMtube	muscle
20	chr10:54014600-54015000	Enhancers	Skeletal Muscle Female	skeletal muscle
21	chr10:54014600-54015200	Enhancers	Skeletal Muscle Male	skeletal muscle
22	chr10:54014800-54015200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
23	chr10:54014800-54016400	Weak transcription	HSMMtube	muscle
24	chr10:54015000-54016600	Weak transcription	Skeletal Muscle Female	skeletal muscle
25	chr10:54015200-54016000	Weak transcription	Skeletal Muscle Male	skeletal muscle
26	chr10:54015200-54018600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
27	chr10:54016000-54017400	Enhancers	HUES64 Cell Line	embryonic stem cell
28	chr10:54016000-54019600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr10:54016000-54019600	Enhancers	Skeletal Muscle Male	skeletal muscle
30	chr10:54016200-54016600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr10:54016200-54016800	Enhancers	Hela-S3	cervix
32	chr10:54016200-54017200	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr10:54016400-54016800	Enhancers	HSMMtube	muscle
34	chr10:54016400-54017200	Enhancers	HMEC	breast
35	chr10:54016400-54017400	Enhancers	HUES6 Cell Line	embryonic stem cell
36	chr10:54016400-54017400	Enhancers	NHEK	skin
37	chr10:54016600-54016800	Active TSS	Skeletal Muscle Female	skeletal muscle
38	chr10:54016600-54016800	Enhancers	GM12878-XiMat	blood
39	chr10:54016600-54017000	Enhancers	Fetal Intestine Large	intestine
40	chr10:54016600-54017200	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr10:54016600-54017200	Enhancers	Muscle Satellite Cultured Cells	--
42	chr10:54016600-54017200	Enhancers	Duodenum Smooth Muscle	Duodenum
43	chr10:54016600-54017200	Enhancers	HSMM	muscle
44	chr10:54016600-54017400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr10:54016600-54017400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr10:54016600-54017400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
47	chr10:54016600-54017400	Enhancers	Rectal Mucosa Donor 31	rectum
48	chr10:54016600-54017400	Enhancers	A549	lung
49	chr10:54016800-54017000	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
50	chr10:54016800-54017200	Flanking Active TSS	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links